New Organization First User QPPV/RP or Change of EU QPPV/RP
New Organization First User QPPV/RP or Change of EU QPPV/RP
New Organization First User QPPV/RP or Change of EU QPPV/RP
EudraVigilance registration documents
IRIS guide for applicants - How to create and submit scientific applications, for industry and individual applicants
First EMA-Animal Health Europe annual bilateral meeting July 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 1 July 2024, 13:30 (CEST) to 1 July 2024, 15:00 (CEST)
Highlights - First EMA-Animal Health Europe annual bilateral meeting July 2024
Final minutes – HMA-EMA joint Big Data Steering Group teleconference from 27 May 2024
EMA is closed on Assumption Day, 15 August
Human medicines European public assessment report (EPAR): Fasturtec, rasburicase, Date of authorisation: 23/02/2001, Revision: 31, Status: Authorised
List of medicines currently in PRIME scheme
Superseded - EMA guidance on the use of medicinal products for the treatment of patients exposed to terrorist attacks with chemical agents